HyperMax
HyperMax, licence 80113778: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- HyperMax Extreme Pre-workout, HyperMax-3D
- Licence holder
- Performax Labs
- NPN or DIN-HM
- 80113778
- Status
- Active licence
- Licence date
- 28 October 2021
- Revision date
- 2 September 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione Source : Théacrine | 50.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 12.0:1.0 Dry plant equivalent : 139.5 mg Potency : 3.0 % Caffeine | 11.625 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 40.0 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 75.0 % Catechins | Not specified | Not calculated |
| Cytidine-5'-pyrophosphate de choline(ester) Source : Citicoline | 100.0 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 500.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 60.0 % Catechins | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 15.0 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 90.0 % Polyphenols | Not specified | Not calculated |
| Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium Source : Bétaïne | 1250.0 mg | Not calculated |
| L-Citrulline Source : Citrulline | 3000.0 mg | Not calculated |
| Acide 3-aminopropanoïque Source : Beta-alanine | 1600.0 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 195.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 50.0:1.0 Dry plant equivalent : 7500.0 mg Potency : 2.5 % Caffeine | 150.0 mg | Not calculated |
| Extrait de fève de café vert Extract : Matériel brut sec Extraction ratio : 12.0:1.0 Dry plant equivalent : 139.5 mg Potency : 0.58 mg Caffeine | 11.625 mg | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 25:1.0 Dry plant equivalent : 31.25 mg | 1.25 mg | Not calculated |
| Prunus cerasus Source : Fruit | 0.125 mg | Not calculated |
| Vaccinium angustifolium Source : Fruit | 0.125 mg | Not calculated |
| Brassica oleracea var. viridis Source : Feuille | 0.125 mg | Not calculated |
| Huperzia serrata Source : Plante entière Potency : 1.0 % Huperzine A | 5.0 mg | Not calculated |
| Brassica oleracea var. italica Source : Sommité | 0.125 mg | Not calculated |
Non-medicinal ingredients
Sucralose, Saveur, Acésulfame potassium, Bleu FD&C n° 1, Tartrazine (Jaune 5), Rouge FD&C N° 40, Dioxyde de silicium, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support liver function. Helps (temporarily) to enhance (physical) energy. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to reduce tiredness and fatigue. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps (temporarily) to support/promote mental sharpness/alertness. Used (temporarily) as a mild diuretic. Source of/Provides antioxidants. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80113778
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.